Metropolitan Life Insurance CO Embecta Corp. Transaction History

Metropolitan Life Insurance CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$12.35 - $19.33 $4,532 - $7,094	-367 Reduced 10.56%	3,108 $41,000
Q3 2023 Nov 14, 2023	BUY	$15.0 - $22.17 $4,965 - $7,338	331 Added 10.53%	3,475 $52,000
Q1 2023 May 15, 2023	SELL	$23.07 - $32.77 $11,281 - $16,024	-489 Reduced 13.46%	3,144 $88,000
Q4 2022 Jun 14, 2023	BUY	$25.29 - $35.48 $12,366 - $17,349	489 Added 15.55%	3,633 $91.9 Million
Q4 2022 Mar 30, 2023	BUY	$25.29 - $35.48 $2,529 - $3,547	100 Added 2.83%	3,633 $91,000
Q4 2022 Feb 15, 2023	BUY	$25.29 - $35.48 $2,529 - $3,547	100 Added 2.83%	3,633 $91,000
Q3 2022 Jun 14, 2023	BUY	$24.0 - $33.42 $9,336 - $13,000	389 Added 12.37%	3,533 $102 Million
Q2 2022 Jun 20, 2023	BUY	$24.78 - $33.36 $9,639 - $12,977	389 Added 12.37%	3,533 $89,000
Q2 2022 Mar 30, 2023	SELL	$24.78 - $33.36 $2,478 - $3,336	-100 Reduced 2.75%	3,533 $89,000
Q2 2022 Aug 11, 2022	BUY	$24.78 - $33.36 $87,547 - $117,860	3,533 New	3,533 $89,000

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.